BOSUTRIS 500MG

BOSUTRIS 500MG TAB contains the active ingredient Bosutinib, which is primarily used to support individuals with certain types of blood cancers, particularly chronic myeloid leukemia (CML). This medication helps manage the disease by inhibiting the action of specific proteins involved in the growth and spread of cancer cells. In doing so, it aims to improve the overall quality of life for patients undergoing treatment.

Bosutinib works by targeting and blocking certain enzymes that contribute to the uncontrolled growth of cancer cells. By disrupting these processes, it may help to slow down the progression of the disease and reduce the number of cancer cells present in the body. This mechanism is tailored to address the unique challenges of CML, providing an option for those affected.

It is important to store BOSUTRIS at room temperature, away from moisture and direct sunlight, ensuring it remains safe and effective. Consistency in use is essential for achieving the desired effects, so taking the medication as prescribed is advisable. Patients should also be aware of any underlying health conditions and discuss them with their healthcare provider to ensure the treatment is suitable.

Common, mild side effects may include nausea, diarrhea, fatigue, and headaches. It is crucial to monitor any reactions and consult a healthcare professional if they persist or worsen.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.